Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Peek Vision is a UK-based social enterprise that provides software and data intelligence platforms for eye health services. It is not a general-purpose SaaS product; instead, it serves governments, international NGOs, and eye health program operators, helping them run vision screening, data collection, follow-up management, and program evaluation in communities, schools, and workplaces. Its core goal is to help health systems identify people with avoidable vision loss and connect them to eye care services.
The platform consists of mobile apps and a web platform. The mobile side enables anyone to conduct vision screening and collect data in the field, with the clinically validated Peek Acuity vision test built in. The web platform provides real-time data visibility for survey monitoring and program oversight. Peek also covers the patient journey from screening through to treatment, using data insights to help service providers improve screening coverage, follow-up attendance, and resource efficiency. Dedicated tools include RAAB7, used for rapid assessment of avoidable blindness among people aged 50 and above, and SEHRA, used for environmental assessment, planning, and monitoring of school eye health programs.
The collected text does not disclose plans, pricing, free trials, or procurement methods, making it difficult to assess its standard SaaS commercial entry requirements. There is also no clear information on third-party integrations, APIs, developer support, team collaboration, or permission management. On security, the text states that data is encrypted and automatically transmitted to secure cloud servers, but it does not disclose specific compliance certifications, data residency options, or audit capabilities. In terms of deployment, a mobile-plus-cloud web platform model is confirmed, while self-hosting is not mentioned.
Its strengths lie in its highly focused vertical use case: the software is designed by eye health experts and is supported by research evidence from JAMA Ophthalmology, The Lancet Global Health, The Lancet Digital Health, and others. It also has implementation experience across multiple countries, with the text stating that partners have screened more than 11 million people in total. The limitation is that it is more of a public health program solution than a ready-to-use general enterprise software product. Key procurement information around commercial terms, integrations, and permissions is not transparent and needs to be confirmed with the vendor.
Peek is suited to government health departments, international development organizations, charitable foundations, eye health NGOs, school eye health programs, and primary-level screening projects. Access from mainland China, payment methods, and local service availability are unknown. If deployed in China, key issues to evaluate include network availability, cross-border data transfer, medical data compliance, RMB payment support, and local alternatives. Potential alternatives may include domestic public health informatization platforms, primary-level screening systems, or hospital ophthalmology information systems.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on peekvision.org official site.
peekvision.org is an United Kingdom SaaS provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach peekvision.org directly.